logo

Stock Screener

Forex Screener

Crypto Screener

SOLV

Solventum Corporation (SOLV)

$

67.14

+0.04 (0.06%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

-0.0574

Market cap

Market cap

11.6 Billion

Price to sales ratio

Price to sales ratio

1.3984

Debt to equity

Debt to equity

0.9972

Current ratio

Current ratio

1.2305

Income quality

Income quality

0.2371

Average inventory

Average inventory

1.1 Billion

ROE

ROE

0.3674



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

Solventum Corporation, a healthcare company incorporated in 2023 and based in Saint Paul, Minnesota, is focused on developing, manufacturing, and commercializing a diverse range of solutions to meet critical customer and patient needs. The company operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers an array of products, including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. Meanwhile, the Dental Solutions segment provides an extensive suite of dental and orthodontic products such as brackets, aligners, restorative cements, and bonding agents. Health Information Systems is dedicated to delivering software solutions like computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. In addition, the Purification and Filtration segment features advanced purification and filtration technologies encompassing filters, purifiers, cartridges, and membranes. The company's operating expenses amount to $2,270,000,000.00 encompassing various operational costs incurred. With reported revenue of $8,325,000,000.00 the company reflects a strong market presence. Moreover, the operating income ratio stands at 0.26 indicating the company's operational profitability margin, while the weighted average number of shares outstanding is 174,100,000.00 highlighting the company's shareholder base. The company's stock is identified with the symbol 'SOLV' in the market. Investors will find the stock reasonably priced at $73.72 appealing to a broad range of market participants. With an average trading volume of 1,088,171.00 the stock indicates moderate liquidity, which can facilitate trading activities for shareholders. Solventum Corporation boasts a mid-range market capitalization of $11,648,320,356.00 establishing it as a steady performer. As a key player in the Medical - Care Facilities industry, the company significantly contributes to the overall market landscape, driving innovation and growth within the healthcare sector, wherein it belongs to the Healthcare sector. This combination of solid financial performance and strategic positioning underscores Solventum Corporation’s potential as a valuable investment opportunity within the dynamic healthcare market.

What is Solventum Corporation (SOLV)'s current stock price?

The current stock price of Solventum Corporation (SOLV) is $66.83 as of 2026-03-20. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in Solventum Corporation (SOLV) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bearish outlook. Always conduct your own research before investing.

Analysts predict Solventum Corporation stock to fluctuate between $60.70 (low) and $88.20 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2026-03-20, Solventum Corporation's market cap is $11,648,320,356, based on 173,493,005 outstanding shares.

Compared to Meta Platforms, Inc. Class A Common Stock, Solventum Corporation has a Lower Market-Cap, indicating a difference in performance.

To buy Solventum Corporation (SOLV) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SOLV. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.

Revenue: $8,325,000,000 | EPS: $8.94 | Growth: 222.74%.

Visit https://www.solventum.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $88.20 (2025-12-02) | All-time low: $47.16 (2024-07-16).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

SOLV

seekingalpha.com

Solventum Corporation (SOLV) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript

Solventum Corporation (SOLV) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript

SOLV

zacks.com

Solventum (SOLV) is a Top-Ranked Value Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

SOLV

seekingalpha.com

Solventum: Improvements Come Slow

Solventum shares have traded sideways post-spin, as investors digest separation impacts, stranded costs, and recent capital allocation moves. Despite a $4.1B divestment and targeted $500M cost savings, 2025 results showed minimal free cash flow and only modest earnings growth. 2026 guidance calls for 2-3% organic sales growth and adjusted EPS of $6.50, but free cash flow remains weak at ~$200M.

SOLV

zacks.com

Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down

SOLV's Q4 earnings and revenues beat estimates, driven by organic growth across MedSurg, Dental and HIS, despite margins declined.

SOLV

seekingalpha.com

Solventum Corporation (SOLV) Q4 2025 Earnings Call Transcript

Solventum Corporation (SOLV) Q4 2025 Earnings Call Transcript

SOLV

zacks.com

Solventum (SOLV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

SOLV

zacks.com

Solventum (SOLV) Surpasses Q4 Earnings and Revenue Estimates

Solventum (SOLV) came out with quarterly earnings of $1.57 per share, beating the Zacks Consensus Estimate of $1.5 per share. This compares to earnings of $1.41 per share a year ago.

SOLV

reuters.com

Solventum beats quarterly estimates on strong demand for surgical products

Medical device maker Solventum on Thursday beat Wall Street estimates for the fourth quarter, helped by strong demand for its wound care and sterilization products.

SOLV

zacks.com

Solventum to Post Q4 Earnings: What's in Store for the Stock?

SOLV readies Q4 results amid solid momentum, tariff headwinds, and M&A focus as investors watch margins and growth trends closely.

SOLV

reuters.com

SOLV Energy fetches $6 billion valuation in strong Nasdaq debut

SOLV Energy's shares rose 20% in its New York debut on Wednesday, giving the solar and battery storage firm a valuation of $5.98 billion, underscoring a strong rebound in IPO activity in 2026.

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener